Akari Therapeutics PLC (AKTX)

1.11 -0.13 (-10.48%) USD  |  NASDAQ  |  Nov 22, 11:02
More

Akari Therapeutics EV to Revenues

EV to Revenues Chart

View EV to Revenues for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to Revenues Data

View and export this data back to . Upgrade now.
Date Value

EV to Revenues Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

DBV Technologies SA --
Cellectis SA Upgrade
Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals PLC Upgrade
NuCana PLC --

EV to Revenues Related Metrics

EV to Free Cash Flow Upgrade